A 48-week telaprevir-based triple combination therapy...

Hepatology Research 2014 / 12 Vol. 44; Iss. 14

A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study

Shimada, Noritomo, Tsubota, Akihito, Atsukawa, Masanori, Abe, Hiroshi, Ide, Tatsuya, Takaguchi, Koichi, Chuganji, Yoshimichi, Toyoda, Hidenori, Yoshizawa, Kai, Ika, Makiko, Sato, Yoshiyuki, Kato, Keiz
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
44
Language:
english
Journal:
Hepatology Research
DOI:
10.1111/hepr.12323
Date:
December, 2014
File:
PDF, 600 KB
english, 2014
Conversion to is in progress
Conversion to is failed